Argenx Se ARGX
NASDAQ ARGX
$962.22 +16.40 (+1.73%)
At close: Sep 24, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Gross Margin (2022 - 2026)

Argenx Se's (ARGX) quarterly Gross Margin came in at 90.43% in Q2 2026, up 210.0% on a YoY basis from 29.17% in Q2 2025, and little changed quarter-over-quarter from 90.68% in Q1 2026.

Analysis

Argenx Se (ARGX) Gross Margin (2022 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Gross Margin for 5 consecutive years, with 90.43% the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Gross Margin rose 210.0% year-over-year to 90.43%; the trailing twelve-month figure through Jun 2026 stood at 89.95% (up 56.0% YoY), and the FY2025 full-year result was 89.14%, down 46.0% from the prior year.
  • Gross Margin was little changed at 90.43% in Q2 2026 per ARGX's latest filing, from 90.68% in the prior quarter.
  • Across five years, Gross Margin topped out at 93.52% in Q1 2022 and bottomed at 88.33% in Q2 2025.
  • Historically, Gross Margin has averaged 90.48% across 5 years, with a median of 90.22% in 2024.
  • The sharpest annual moves came in 2023 and 2026: Gross Margin plunged 317 bps in 2023, then jumped 210 bps in 2026.
  • Over 5 years, Gross Margin stood at 92.63% in 2022, then declined by 3 bps to 89.45% in 2023, then climbed by 1 bps to 90.14% in 2024, then fell by 2 bps to 88.36% in 2025, then grew by 2 bps to 90.43% in 2026.
  • According to Business Quant data, Gross Margin over the past three periods registered 90.43%, 90.68%, and 88.36% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 68.19%
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 74.74%
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 73.54%
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 78.02%
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 83.60%
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 72.04%
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 79.76%
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 85.33%
10 Argenx Se 58.53 Bn 53.35 Bn 1.37 Bn 90.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 90.43%
Mar 31, 2026 90.68%
Dec 31, 2025 88.36%
Sep 30, 2025 90.29%
Jun 30, 2025 88.33%
Mar 31, 2025 89.75%
Dec 31, 2024 90.14%
Sep 30, 2024 89.69%
Jun 30, 2024 89.03%
Mar 31, 2024 89.16%
Dec 31, 2023 89.45%
Sep 30, 2023 89.06%
Jun 30, 2023 91.08%
Mar 31, 2023 91.59%
Dec 31, 2022 92.63%
Sep 30, 2022 92.18%
Jun 30, 2022 93.31%
Mar 31, 2022 93.52%
API Access

Argenx Se Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=ARGX&period=max&api_key=YOUR_API_KEY